Emerging drug therapies for diabetes focus on innovative approaches such as dual or triple agonists targeting GLP-1, GIP, and glucagon receptors, offering enhanced glucose control and weight management. Novel oral insulin formulations aim to simplify administration and improve patient adherence. Advanced therapies like stem cell-derived beta-cell transplants and gene editing hold promise for potentially reversing diabetes by addressing its root causes.
6.1 SGLT2 inhibitors for cardiovascular risk reduction
6.2 GLP-1 receptor agonists and weight management
6.3 Dual agonists for glucose and weight control
6.4 Novel oral insulin formulations
6.5 Small-molecule therapies targeting insulin pathways
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
